Amarin Corp Plc (AMRN)

[sstyles]

People have lost sight of the forest for the trees and are getting bogged down in minutiae.

Hikma's CEO and other CEOs of generics are not going to launch materially or launch at all until the GSK v. Teva case is fully resolved. Look at their market caps then look at potential damages. You don't risk your company on this.

You can analyze that case a thousand ways if you want. The damages are too great and I should not have to tell you that courts can be uncertain. You are not risking your company on trying to game plan on how not to infringe by writing not for CVD or any other novel ideas folks come up with.

Not happening. I am confident on this. Won't keep writing on this but it's comical how much has been discussed about how this case does not pertain to Amarin. Comical. I assure you big pharma is aware of how it keeps generics at bay until fully resolved.


Damages are too significant. End of story.